Annex Advisory Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Buy |
69,130
+9,264
| +15% | +$2.03M | 0.36% | 58 |
|
|
2025
Q1 | $13.4M | Buy |
59,866
+11,218
| +23% | +$2.51M | 0.38% | 59 |
|
|
2024
Q4 | $15.9M | Buy |
48,648
+12,568
| +35% | +$4.12M | 0.48% | 48 |
|
|
2024
Q3 | $10.8M | Buy |
36,080
+10,900
| +43% | +$3.27M | 0.35% | 59 |
|
|
2024
Q2 | $8.29M | Buy |
25,180
+4,186
| +20% | +$1.38M | 0.29% | 59 |
|
|
2024
Q1 | $8.31M | Sell |
20,994
-10,555
| -33% | -$4.18M | 0.3% | 57 |
|
|
2023
Q4 | $11.1M | Buy |
31,549
+6,169
| +24% | +$2.17M | 0.46% | 47 |
|
|
2023
Q3 | $9.52M | Buy |
25,380
+6,558
| +35% | +$2.46M | 0.58% | 45 |
|
|
2023
Q2 | $7.2M | Sell |
18,822
-863
| -4% | -$330K | 0.4% | 50 |
|
|
2023
Q1 | $6.82M | Buy |
19,685
+10,883
| +124% | +$3.77M | 0.37% | 45 |
|
|
2022
Q4 | $2.07M | Buy |
+8,802
| New | +$2.07M | 0.12% | 89 |
|